Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Neuroscience Research

• Publication date

  2018-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jnr.24224PMID 29446144
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PL‐03‐01: INGE GRUNDKE‐IQBAL AWARD FOR ALZHEIMER'S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA

  2019cited by this paper
• Strain differences in cuprizone induced demyelination

  2017cited by this paper
• Lewis Rat Model of Experimental Autoimmune Encephalomyelitis

  2017cited by this paper
• Histological validation of fast macromolecular proton fraction mapping as a quantitative myelin imaging method in the cuprizone demyelination model

  2017cited by this paper
• Widespread cortical demyelination of both hemispheres can be induced by injection of pro‐inflammatory cytokines via an implanted catheter in the cortex of MOG‐immunized rats

  2017cited by this paper
• Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy.

  2017cited by this paper
• Neurotoxic reactive astrocytes are induced by activated microglia

  2017cited by this paper
• Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis

  2017cited by this paper
• Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone‐induced demyelination

  2017cited by this paper
• Reactive Astrocytes: Production, Function, and Therapeutic Potential.

  2017cited by this paper
• Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies.

  2017cited by this paper
• Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression

  2017cited by this paper
• Multiple sclerosis animal models: a clinical and histopathological perspective

  2017cited by this paper
• Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself

  2016cited by this paper
• Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice

  2016cited by this paper
• Focal Injection of Ethidium Bromide as a Simple Model to Study Cognitive Deficit and Its Improvement

  2016cited by this paper
• Experimental Autoimmune Encephalomyelitis in Mice.

  2016cited by this paper
• Ozone Therapy in Ethidium Bromide-Induced Demyelination in Rats: Possible Protective Effect

  2016cited by this paper
• Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain

  2016cited by this paper
• Multiple sclerosis: experimental models and reality

  2016cited by this paper
• Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte Glycoprotein

  2016cited by this paper
• Animal models of Multiple Sclerosis

  2015cited by this paper
• Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

  2015cited by this paper
• Low-Dose Ribavirin Treatments Attenuate Neuroinflammatory Activation of BV-2 Cells by Interfering with Inducible Nitric Oxide Synthase

  2015cited by this paper
• Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?

  2015cited by this paper
• Benfotiamine Attenuates Inflammatory Response in LPS Stimulated BV-2 Microglia

  2015cited by this paper
• Cell death of spinal cord ED1+ cells in a rat model of multiple sclerosis

  2015cited by this paper
• Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells

  2015cited by this paper
• Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice

  2015cited by this paper
• Analysis of Neurogenesis during Experimental Autoimmune Encephalomyelitis Reveals Pitfalls of Bioluminescence Imaging

  2015cited by this paper
• Male rats develop more severe experimental autoimmune encephalomyelitis than female rats: sexual dimorphism and diergism at the spinal cord level.

  2015cited by this paper
• Expression of a Second Ecto-5′-Nucleotidase Variant Besides the Usual Protein in Symptomatic Phase of Experimental Autoimmune Encephalomyelitis

  2015cited by this paper
• Class II HLA interactions modulate genetic risk for multiple sclerosis

  2015cited by this paper
• Inefficient clearance of myelin debris by microglia impairs remyelinating processes

  2015cited by this paper
• Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

  2015cited by this paper
• Whole-Body In Vivo Monitoring of Inflammatory Diseases Exploiting Human Interleukin 6-Luciferase Transgenic Mice

  2015cited by this paper
• Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats.

  2014cited by this paper
• Relapsing–Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells

  2014cited by this paper
• This information is current as Central Nervous System Facilitating Reactivation of T Cells in the Autoimmune Encephalomyelitis by B Cells Promote Induction of Experimental Goverman

  2014cited by this paper
• Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned

  2014influential reference
• Parent-of-Origin Effects Implicate Epigenetic Regulation of Experimental Autoimmune Encephalomyelitis and Identify Imprinted Dlk1 as a Novel Risk Gene

  2014cited by this paper
• The formation of inflammatory demyelinated lesions in cerebral white matter

  2014cited by this paper
• EAE is not a useful model for demyelinating disease.

  2014cited by this paper
• XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis

  2014cited by this paper
• Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum

  2014cited by this paper
• Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely.

  2014cited by this paper
• Axonal loss in multiple sclerosis: causes and mechanisms.

  2014cited by this paper
• Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice

  2014cited by this paper
• The Contribution of Immune and Glial Cell Types in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

  2014cited by this paper
• Policy: NIH to balance sex in cell and animal studies

  2014cited by this paper
• Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice

  2013cited by this paper
• Theiler’s murine encephalomyelitis virus as an experimental model system to study the mechanism of blood–brain barrier disruption

  2013cited by this paper
• Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

  2013cited by this paper
• Functional diversity of microglia – how heterogeneous are they to begin with?

  2013cited by this paper
• Cuprizone-induced demyelination in Wistar rats; electrophysiological and histological assessment.

  2013cited by this paper
• Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss

  2013cited by this paper
• The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis

  2013cited by this paper
• Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis

  2013cited by this paper
• Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.

  2013cited by this paper
• Functional consequences of ethidium bromide demyelination of the mouse ventral spinal cord.

  2013cited by this paper
• Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.

  2013cited by this paper
• Functional Imaging of Rel Expression in Inflammatory Processes Using Bioluminescence Imaging System in Transgenic Mice

  2013cited by this paper
• Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis

  2013cited by this paper
• Preclinical Retinal Neurodegeneration in a Model of Multiple Sclerosis

  2012cited by this paper
• The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.

  2012influential reference
• Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination

  2012cited by this paper
• The evidence for a role of B cells in multiple sclerosis

  2012cited by this paper
• Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages

  2012cited by this paper
• Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.

  2012cited by this paper
• Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis

  2012cited by this paper
• Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

  2012cited by this paper
• Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus

  2012cited by this paper
• The Role of Natural Killer Cells in Multiple Sclerosis and Their Therapeutic Implications

  2012cited by this paper
• B-Cell Depletion Abrogates T Cell–Mediated Demyelination in an Antibody-Nondependent Common Marmoset Experimental Autoimmune Encephalomyelitis Model

  2012cited by this paper
• Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.

  2012cited by this paper
• Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.

  2011cited by this paper
• An Animal Model of Cortical and Callosal Pathology in Multiple Sclerosis

  2011cited by this paper
• De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.

  2011cited by this paper
• Critical appraisal of animal models of multiple sclerosis

  2011cited by this paper
• Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis

  2011cited by this paper
• Mouse models for multiple sclerosis: historical facts and future implications.

  2011influential reference
• Astrocytes in the tempest of multiple sclerosis

  2011cited by this paper
• The role of antigen presenting cells in multiple sclerosis.

  2011cited by this paper
• Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)

  2011cited by this paper
• Astrocyte phenotypes and their relationship to myelination

  2011cited by this paper
• BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions.

  2011influential reference
• Physiology of microglia.

  2011cited by this paper
• Experimental models of multiple sclerosis.

  2011cited by this paper
• Induction of Progressive Demyelinating Autoimmune Encephalomyelitis in Common Marmoset Monkeys Using MOG34-56 Peptide in Incomplete Freund Adjuvant

  2010cited by this paper
• Multiple loci comprising immune-related genes regulate experimental neuroinflammation

  2010cited by this paper
• Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.

  2010cited by this paper
• Focal experimental autoimmune encephalomyelitis in the lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor

  2010cited by this paper
• A critical role for virus-specific CD8(+) CTLs in protection from Theiler's virus-induced demyelination in disease-susceptible SJL mice.

  2010cited by this paper
• Age-Related and Cuprizone-Induced Changes in Myelin and Transcription Factor Gene Expression and in Oligodendrocyte Cell Densities in the Rostral Corpus Callosum of Mice

  2010cited by this paper
• Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle

  2010cited by this paper
• Experimental Autoimmune Encephalomyelitis in the Common Marmoset, a Bridge Between Rodent EAE and Multiple Sclerosis for Immunotherapy Development

  2010cited by this paper
• Neuropathogenesis of Theiler’s Murine Encephalomyelitis Virus Infection, An Animal Model for Multiple Sclerosis

  2010cited by this paper
• Viral Infection Triggers Central Nervous System Autoimmunity Via Activation of Dual TCR-Expressing CD8+ T Cells

  2010cited by this paper
• Quantification of Myelin and Axon Pathology During Relapsing Progressive Experimental Autoimmune Encephalomyelitis in the Biozzi ABH Mouse

  2009cited by this paper
• Experimental Autoimmune Encephalomyelitis in the Rat

  2009cited by this paper

• EAE models of neuropathic pain in multiple sclerosis do not require pertussis toxin.

  2026cites this paper
• Nebulized bone marrow-derived stem cell supernatant induces tolerogenic dendritic cells via upregulation of FOXO3 for EAE treatment

  2026cites this paper
• Stem cells therapy in neurodegenerative and neuroimmune diseases: current status of treatments and future prospects.

  2025cites this paper
• Attenuation of experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice by Licochalcone A

  2025cites this paper
• The Role of Retinal Antigen-Presenting Cells in Spontaneous Retinal Autoimmunity

  2025cites this paper
• Intranasal Administration of Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Has Therapeutic Effect in Experimental Autoimmune Encephalomyelitis

  2025cites this paper
• Research progress of SOCS in autoimmune diseases: mechanisms and therapeutic implications

  2025cites this paper
• Critical analysis of translational potential of rodent models of white matter pathology across a wide spectrum of human diseases

  2025cites this paper
• Myelin dysfunction in aging and brain disorders: mechanisms and therapeutic opportunities

  2025cites this paper
• Oligodendrocyte and Myelin Pathophysiology in Multiple Sclerosis.

  2025cites this paper
• Expression Patterns of miRNA in the Experimental Autoimmune Encephalomyelitis (EAE)/MS Model Treated With Oenothera biennis Oil

  2025cites this paper
• Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases.

  2025cites this paper
• Febrile temperature-regulated TRPV1 in CD4+ T cells mediates neuroinflammation in complex febrile seizures

  2025cites this paper
• A New Perspective on Mechanisms of Neurodegeneration in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: the Early and Critical Role of Platelets in Neuro/Axonal Loss

  2025cites this paper
• Experimental autoimmune encephalomyelitis causes skeletal muscle dysfunction in mice

  2025cites this paper
• Preparation and evaluation of pomegranate seed oil nanoemulsions for delivery of fingolimod hydrochloride in multiple sclerosis treatment

  2025cites this paper
• Dysregulation of miR-223, miR-146a, and miR-193a Expression Profile in Acute and Chronic Phases of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice

  2024cites this paper
• VCAM-1+ Mesenchymal Stem/Stromal Cells Reveal Preferable Efficacy Upon an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis Over the VCAM-1− Counterpart

  2024cites this paper
• Proteome Profiling of Experimental Autoimmune Encephalomyelitis Mouse Model and the Effect of a SUMO E1 Inhibitor.

  2024cites this paper
• Microglia-astrocyte crosstalk is regulated by Astragalus polysaccharides mediated through suppression of Sema4D-PlexinB2 signaling in experimental autoimmune encephalomyelitis.

  2024cites this paper
• Pectin-stabilized nanoceria double coated with lactoferrin/chitosan for management of experimental autoimmune encephalomyelitis.

  2024cites this paper
• Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis

  2024cites this paper
• Understanding the Complex Dynamics of Immunosenescence in Multiple Sclerosis: From Pathogenesis to Treatment

  2024cites this paper
• Functional Role of DDR1 in Oligodendrocyte Signaling Mechanism in Association with Myelination and Remyelination Process in the Central Nerve System.

  2024cites this paper
• Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis

  2024cites this paper
• Impaired olfactory performance and anxiety-like behavior in a rat model of multiple sclerosis are associated with enhanced adenosine signaling in the olfactory bulb via A1R, A2BR, and A3R

  2024cites this paper
• Cellular Therapy in Experimental Autoimmune Encephalomyelitis as an Adjuvant Treatment to Translate for Multiple Sclerosis

  2024cites this paper
• Mild Disease Course of Experimental Autoimmune Encephalomyelitis without Pertussis Toxin: Brain Transcriptome Analysis Reveals Similar Signaling to Active Lesions in Multiple Sclerosis

  2024cites this paper
• Experimental Autoimmune Encephalomyelitis Influences GH-Axis in Female Rats

  2024cites this paper
• Selected cannabis cultivars modulate glial activation: in vitro and in vivo studies

  2024cites this paper
• Experimental Animal Models in Neurological Diseases

  2024cites this paper
• Extracellular Purine Metabolism—Potential Target in Multiple Sclerosis

  2024cites this paper
• Active Induction of a Multiple Sclerosis-Like Disease in Common Laboratory Mouse Strains.

  2024cites this paper
• Profiling Blood-Based Neural Biomarkers and Cytokines in Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Using Single-Molecule Array Technology

  2023cites this paper
• Delimiting MOGAD as a disease entity using translational imaging

  2023cites this paper
• Neuroprotective effect of curcumin against experimental autoimmune encephalomyelitis-induced cognitive and physical impairments in mice: an insight into the role of the AMPK/SIRT1 pathway

  2023cites this paper
• Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity.

  2023cites this paper
• Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis.

  2023cites this paper
• Cerebellar pathology in multiple sclerosis and experimental autoimmune encephalomyelitis: current status and future directions

  2023cites this paper
• Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis.

  2023cites this paper
• Autoimmune receptor encephalitis in ApoE‑/‑ mice induced by active immunization with NMDA1

  2023cites this paper
• miR-20b-5p exerts protective effects against experimental autoimmune encephalomyelitis in mice by inhibiting NLRP3 transcription and NLRP3/ASC/caspase-1 axis activation

  2023cites this paper
• Human BBB-on-a-chip reveals barrier disruption, endothelial inflammation, and T cell migration under neuroinflammatory conditions

  2023cites this paper
• Modulation of Gut Microbiome Community Mitigates Multiple Sclerosis in a Mouse Model: The Promising Role of Palmaria palmata Alga as a Prebiotic

  2023cites this paper
• Inhibition of CXCR2 enhances CNS remyelination via modulating PDE10A/cAMP signaling pathway.

  2023cites this paper
• Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis

  2023cites this paper
• How myeloid cells shape experimental autoimmune encephalomyelitis: At the crossroads of outside‐in immunity

  2023influential citation
• An overall view of the most common experimental models for multiple sclerosis.

  2023cites this paper
• Neuropathic-like Nociception and Spinal Cord Neuroinflammation Are Dependent on the TRPA1 Channel in Multiple Sclerosis Models in Mice

  2023cites this paper
• Involvement of Degenerating 21.5 kDa Isoform of Myelin Basic Protein in the Pathogenesis of the Relapse in Murine Relapsing–Remitting Experimental Autoimmune Encephalomyelitis and MS Autopsied Brain

  2023cites this paper
• Alpha4 beta7 integrin controls Th17 cell trafficking in the spinal cord leptomeninges during experimental autoimmune encephalomyelitis

  2023cites this paper
• Mesenchymal stem cell-derived exosomal microRNA-367-3p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting EZH2.

  2023cites this paper
• Effectiveness of exercise interventions in animal models of multiple sclerosis

  2023cites this paper
• Exosomal miR-23b-3p from bone mesenchymal stem cells alleviates experimental autoimmune encephalomyelitis by inhibiting microglial pyroptosis.

  2023cites this paper
• Citrullinated human and murine MOG35-55 display distinct biophysical and biochemical behavior.

  2023cites this paper
• First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod

  2023influential citation
• Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?

  2022cites this paper
• Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis.

  2022cites this paper
• Vitamin B Complex and Experimental Autoimmune Encephalomyelitis –Attenuation of the Clinical Signs and Gut Microbiota Dysbiosis

  2022cites this paper
• The innovative animal monitoring device for experimental autoimmune encephalomyelitis ("I AM D EAE"): A more detailed evaluation for improved results.

  2022cites this paper
• Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?

  2022cites this paper
• (R)-ketamine as prophylactic and therapeutic drug for neurological disorders: beyond depression.

  2022cites this paper
• Demyelination Lesions Do Not Correlate with Clinical Manifestations by Bordetella pertussis Toxin Concentrations

  2022cites this paper
• The Role of ASIC1a in Inflammatory Immune Diseases: A Potential Therapeutic Target

  2022cites this paper
• Nrf2/HO-1 Signaling Stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple Sclerosis

  2022cites this paper
• Convergence of human and veterinary medicine: leveraging canine naturally occurring neurological disorders to develop regenerative treatments

  2022influential citation
• The Beneficial Effects of Resveratrol on Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6J Mouse Model

  2022cites this paper
• Stem cell therapy for cuprizone model of multiple sclerosis focusing on the effectiveness of different injection methods and cell labeling.

  2022cites this paper
• Cell‐based experimental strategies for myelin repair in multiple sclerosis

  2022cites this paper
• A Review on Neurodegenerative Diseases with their Suitable Animal Models

  2022cites this paper
• Cell therapy procedure using anti‐inflammatory macrophage M2 can potentially reduce Clinical Score in animals with Experimental Autoimmune Encephalomyelitis: A preclinical systematic review and meta‐analysis study

  2022cites this paper
• Drug-induced microglial phagocytosis in multiple sclerosis and experimental autoimmune encephalomyelitis and the underlying mechanisms

  2022cites this paper
• Mesenchymal stromal cell extracellular vesicles for multiple sclerosis in preclinical rodent models: A meta-analysis

  2022cites this paper
• Research progress of statins on immune regulation of multiple sclerosis and experimental allergic encephalomyelitis.

  2022cites this paper
• Effects of Ocrelizumab on Dental Pulp Derived Mesenchymal Stem Cells

  2022cites this paper
• Cuprizone-Dependent De/Remyelination Responses and Functional Correlates in Mouse Strains Adopted to Model Relapsing, Chronic and Progressive Experimental Autoimmune Encephalomyelitis

  2021cites this paper
• Quantitative analysis of spinal cord neuropathology in experimental autoimmune encephalomyelitis.

  2021cites this paper
• Regular Exercise Training Enhances Spatial Memory and Regulates Glucocorticoid System in Experimental Autoimmune Encephalomyelitis

  2021cites this paper
• Exploring Experimental Autoimmune Encephalomyelitis as an Animal Model to Study Trigeminal Dysfunction in Multiple Sclerosis

  2021cites this paper
• (R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in mice.

  2021cites this paper
• Vitamin D in Multiple Sclerosis—Lessons From Animal Studies

  2021cites this paper
• Neurodegenerative Disease: What Potential Therapeutic Role of Acid-Sensing Ion Channels?

  2021cites this paper
• Chia oil prevents chemical and immune-mediated inflammatory responses in mice: Evidence for the underlying mechanisms.

  2021cites this paper
• Nanosystems and exosomes as future approaches in treating multiple sclerosis

  2021cites this paper
• T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis

  2021cites this paper
• Immunosenescence in multiple sclerosis: The identification of new therapeutic targets.

  2021cites this paper
• Connecting Neuroinflammation and Neurodegeneration in Multiple Sclerosis: Are Oligodendrocyte Precursor Cells a Nexus of Disease?

  2021cites this paper
• The Function of the Hypothalamic–Pituitary–Adrenal Axis During Experimental Autoimmune Encephalomyelitis: Involvement of Oxidative Stress Mediators

  2021cites this paper
• Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials

  2021cites this paper
• TAM Signaling in the Nervous System

  2021influential citation
• Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models

  2021cites this paper
• Translational Block in Stroke: A Constructive and “Out-of-the-Box” Reappraisal

  2021cites this paper
• Experimental Autoimmune Encephalomyelitis.

  2021cites this paper
• Exploring the Sexual Dimorphism of Crustacean Neuropeptide Expression Using Callinectes sapidus as a Model Organism.

  2021cites this paper
• Modulatory response of chrysin supplementation in a experimental autoimmune encephalomyelitis model: Evaluation of microRNAs influence

  2021cites this paper
• An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview

  2021cites this paper
• Preclinical Therapy with Vitamin D3 in Experimental Encephalomyelitis: Efficacy and Comparison with Paricalcitol

  2021cites this paper
• Insights into the role of B cells in the cortical pathology of Multiple sclerosis: evidence from animal models and patients.

  2021cites this paper
• Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain

  2021cites this paper
• Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis

  2021influential citation